Study found DNA-based screen was more than 90 percent accurate in predicting recurrence
by yela3568 on Thu May 06, 2010 05:14 PM
Any advice/thoughts would be greatly appreciated. I'm thinking of starting my mom (56 years old/ colorectal with mests to the liver) on this treatment and would love to get some additional info. She also has a permanent colostomy.
by andy73 on Thu May 06, 2010 06:05 PM
Excellent, highly recommended
Look in 'Supplements' section on this site under 'Nutrition'
by andy73 on Fri May 07, 2010 12:37 AM
Really good article on the Budwig protocol and its background
since the 1950's with Dr Budwig
by jmi526 on Thu Jul 22, 2010 02:59 AM
My father had pancreatic cancer and took Cellect. The very first day he no longer had pain and was only taking a pain pill at night. Then he no longer took the pain pills after a few days. He previously was constantly asking if it was time yet to take his next pill. The doctors and nurses were amazed and also could not believe he was up and out of bed considering he was stage IV and how advanced his cancer was. Unfortunately I did not discover Cellect sooner. I believe that had I found it sooner he may still be with us or at least extended his life. He only started taking it about 6 weeks before he passed away and was only in bed the final week. Best of luck to you and your mom.
When you track a discussion, you will get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to track this discussion?
If you stop tracking this discussion, you will no longer get notified by e-mail if anyone else posts a new message on this discussion. Are you sure you want to stop tracking this discussion?
If you were considering traveling for cancer treatment, which headline would you find more interesting?
Destination: HOPE. Cancer care that is worth the trip.
Over 84% of our patients travel to our hospital from another state
Neither headline is interesting
We care about your feedback. Let us know how we can improve your CancerCompass experience.